Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Hematopathology|April 10, 2026
SSTR2 expression in EBV-positive and EBV-negative lymphomasNivaz Brar, Juan Carlos Barrios-Menéndez, Gregory W Charville, et al.
The Journal of Clinical Investigation|March 2, 2012
Evidence for a stepwise program of extrathymic T cell development within the human tonsilSusan McClory, Tiffany Hughes, Aharon G Freud, et al.
Cell Reports|June 24, 2014
The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cellsTiffany Hughes, Edward L Briercheck, Aharon G Freud, et al.
Cancer Immunology, Immunotherapy : CII|October 29, 2013
Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCCShauna M Collins, Courtney E Bakan, Gina D Swartzel, et al.
Blood Advances|May 14, 2021
Low-cost transcriptional diagnostic to accurately categorize lymphomas in low- and middle-income countriesFabiola Valvert, Oscar Silva, Elizabeth Solórzano-Ortiz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 27, 2017
IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κBAaron R Victor, Ansel P Nalin, Wenjuan Dong, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2015
PTEN is a negative regulator of NK cell cytolytic functionEdward L Briercheck, Rossana Trotta, Li Chen, et al.
Nature Communications|February 10, 2025
Single-cell RNA sequencing defines distinct disease subtypes and reveals hypo-responsiveness to interferon in asymptomatic Waldenstrom's MacroglobulinemiaRomanos Sklavenitis-Pistofidis, Yoshinobu Konishi, Daniel Heilpern-Mallory, et al.
Blood Advances|May 30, 2024
Geographic EBV variants confound disease-specific variant interpretation and predict variable immune therapy responsesEdward L Briercheck, Shashidhar Ravishankar, Elshafa Hassan Ahmed, et al.
Pageof 2